The results showed that primed immune CD4+ T cells could not re-establish full protection from challenge with CIITA-negative parental tumor, strongly suggesting that primed anti-tumor CD4+ Th cells could trigger and activate tumor-specific naïve CD8+ T cells to make them fully mature anti-tumor CTL effectors [43]. This evidence concerns the gene CD8A and neoplasm.